CSIMarket
 


Boston Scientific Corporation  (BSX)
Other Ticker:  
 

Boston Scientific's Leverage Ratio

BSX's quarterly Leverage Ratio and Total Liabilities, Equity growth


Due to net new borrowings of 4.12%, Leverage Ratio fell to 0.7, below the Boston Scientific's average Leverage Ratio.

Within Medical Equipment & Supplies industry in the forth quarter 2023, 21 other companies have achieved lower Leverage Ratio than Boston Scientific in the IV Quarter 2023. While Leverage Ratio total ranking has improved so far in the forth quarter 2023 to 328, from total ranking in the third quarter 2023 at 1328 .

Explain Leverage Ratio?
Who are BSX Customers?
What are BSX´s Total Liabilities?


BSX Leverage Ratio (Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Equity Change 11.14 % 8.44 % 7.15 % 8.21 % 5.72 %
Y / Y Total Liabilities Change 8.13 % 9.04 % -9.26 % -17.72 % -18.51 %
Leverage Ratio MRQ 0.7 0.69 0.72 0.71 0.72
BSX's Total Ranking # 328 # 1328 # 453 # 1116 # 427
Seq. Equity Change 2.1 % 3.48 % 2.08 % 3.05 % -0.38 %
Seq. Total Liabilities Change 4.12 % -0.8 % 3.72 % 0.94 % 4.99 %



Leverage Ratio forth quarter 2023 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 22
Healthcare Sector # 72
Overall Market # 328


Leverage Ratio Statistics
High Average Low
1.87 1.17 0.69
(Dec 31 2015)   (Sep 30 2022)




Financial Statements
Boston Scientific's Equity $ 19,530 Millions Visit BSX's Balance sheet
Boston Scientific's Total Liabilities $ 13,752 Millions Visit BSX's Balance sheet
Source of BSX's Sales Visit BSX's Sales by Geography


Cumulative Boston Scientific's Leverage Ratio

BSX's Leverage Ratio for the trailling 12 Months

BSX Leverage Ratio

(Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Equity TTM Growth 11.14 % 8.44 % 7.15 % 8.21 % 5.72 %
Y / Y Total Liabilities TTM Growth 8.13 % 9.04 % -9.26 % -17.72 % -18.51 %
Leverage Ratio TTM 0.71 0.71 0.71 0.74 0.8
Total Ranking TTM # 3 # 1239 # 90 # 8 # 6
Seq. Equity TTM Growth 2.1 % 3.48 % 2.08 % 3.05 % -0.38 %
Seq. Total Liabilities TTM Growth 4.12 % -0.8 % 3.72 % 0.94 % 4.99 %


On the trailing twelve months basis Despite of the net new borrowings of 4.12% during the twelve months period ending in IV Quarter 2023 Boston Scientific has managed to unchanged Leverage Ratio in the IV Quarter 2023 to 0.71, below Boston Scientific's average Leverage Ratio.
Leverage Ratio is the average cumulative value over the last four quarters.

Among companies in the Medical Equipment & Supplies industry BSX recorded the lowest Leverage Ratio. While Leverage Ratio total ranking has improved so far to 3, from total ranking in previous 12 month period at 1239.

Explain Leverage Ratio?
Who are BSX Customers?
What are BSX´s Total Liabilities?

TTM Leverage Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 0
Healthcare Sector # 1
Within the Market # 3


trailing twelve months Leverage Ratio Statistics
High Average Low
1.83 1.19 0.8
(Sep 30 2016)   (Dec 31 2023)




Companies with similar Leverage Ratio in the quarter ending Dec 31 2023, within Medical Equipment & Supplies Industry Leverage RatioDec 31 2023 MRQ Total LiabilitiesDec 31 2023 MRQ Equity
Novocure Limited  1.93 $ 698.909  Millions$ 362.496  Millions
Zynex inc   1.88 $ 86.850  Millions$ 46.129  Millions
Tandem Diabetes Care Inc   1.84 $ 577.972  Millions$ 313.632  Millions
Artivion Inc   1.81 $ 510.617  Millions$ 281.780  Millions
Intelligent Bio Solutions Inc   1.76 $ 5.547  Millions$ 3.154  Millions
Conmed Corporation  1.68 $ 1,404.897  Millions$ 834.222  Millions
Stereotaxis Inc   1.56 $ 25.566  Millions$ 16.343  Millions
Escalon Medical Corp   1.56 $ 2.869  Millions$ 1.837  Millions
Henry Schein Inc  1.36 $ 5,840.000  Millions$ 4,289.000  Millions
Shockwave Medical Inc   1.34 $ 897.886  Millions$ 668.677  Millions
Beyond Air Inc   1.32 $ 31.097  Millions$ 23.471  Millions
Cytosorbents Corporation  1.29 $ 29.985  Millions$ 23.275  Millions
Msa Safety Incorporated  1.24 $ 1,203.348  Millions$ 966.802  Millions
Masimo Corp  1.23 $ 1,676.700  Millions$ 1,364.800  Millions
Cadre Holdings Inc   1.19 $ 234.017  Millions$ 197.162  Millions
Haemonetics Corporation  1.19 $ 1,118.604  Millions$ 943.319  Millions
Integra Lifesciences Holdings Corp  1.18 $ 1,878.914  Millions$ 1,587.884  Millions
Quoin Pharmaceuticals Ltd   1.15 $ 6.505  Millions$ 5.664  Millions
Electrocore Inc   1.08 $ 8.034  Millions$ 7.442  Millions
Adm Tronics Unlimited Inc   1.06 $ 1.168  Millions$ 1.103  Millions
Glaukos Corp  1.04 $ 478.648  Millions$ 461.766  Millions
National Vision Holdings Inc   1.02 $ 848.471  Millions$ 829.418  Millions
Clearpoint Neuro Inc   1.01 $ 21.488  Millions$ 21.173  Millions
Icu Medical Inc  0.99 $ 2,094.668  Millions$ 2,123.410  Millions
Irhythm Technologies Inc   0.97 $ 204.582  Millions$ 210.097  Millions
Encision Inc   0.95 $ 2.094  Millions$ 2.193  Millions
Bausch and Lomb Corp  0.95 $ 6,592.000  Millions$ 6,920.000  Millions
Integer Holdings Corporation  0.93 $ 1,414.919  Millions$ 1,519.042  Millions
Merit Medical Systems Inc  0.92 $ 1,111.157  Millions$ 1,202.000  Millions
Livanova Plc  0.90 $ 1,151.935  Millions$ 1,277.628  Millions

Date modified: 2024-02-21T14:38:19+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com